Clinical trial
The Efficacy and Safety of Hypertonic Lactate Solution as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG (Coronary Artery Bypass Grafting) Patients
NCT00529490 is registered in ClinicalTrials.gov with Innogene Kalbiotech Pte. Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Hypertonic Lactate Solution as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG (Coronary Artery Bypass Grafting) Patients
- Lead sponsor
- Innogene Kalbiotech Pte. Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- June 30, 2003
- Enrollment
- 230 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
low cardiac output